Value of Preoperative CA 125 Level in the Management of Uterine Cancer and Prediction of Clinical Outcome

[1]  R. Buller,et al.  Obesity and prognosis in endometrial cancer. , 1996, American journal of obstetrics and gynecology.

[2]  P. Disaia,et al.  CA 125 kinetics: a cost-effective clinical tool to evaluate clinical trial outcomes in the 1990s. , 1996, American journal of obstetrics and gynecology.

[3]  P. Wingo,et al.  Cancer statistics, 1996 , 1996, CA: a cancer journal for clinicians.

[4]  P. Sevelda,et al.  Preoperative CA 125: An Independent Prognostic Factor in Patients With Stage I Epithelial Ovarian Cancer , 1995, Obstetrics and gynecology.

[5]  R. Buller,et al.  Steroid hormone receptor content and lymph node status in endometrial cancer. , 1995, Gynecologic oncology.

[6]  P. Rose,et al.  Serial Serum CA 125 Measurements for Evaluation of Recurrence in Patients With Endometrial Carcinoma , 1994, Obstetrics and gynecology.

[7]  P. Disaia,et al.  What is a normal CA125 level? , 1994, Gynecologic oncology.

[8]  E. Kuşçu,et al.  Accuracy of pipelle endometrial sampling in endometrial carcinoma. , 1994, Gynecologic and obstetric investigation.

[9]  R. Buller,et al.  Serum CA125 regression in epithelial ovarian cancer: correlation with reassessment findings and survival. , 1992, Gynecologic oncology.

[10]  L. Bloss,et al.  Use of vaginal hysterectomy for the management of stage I endometrial cancer in the medically compromised patient. , 1991, Gynecologic oncology.

[11]  M. Schemper,et al.  CA 125 as an independent prognostic factor for survival in patients with epithelial ovarian cancer. , 1989, American journal of obstetrics and gynecology.

[12]  K. Hatch,et al.  Value of serum 125Ca levels: does the result preclude second look? , 1989, Gynecologic oncology.

[13]  G. Fleuren,et al.  Tumor Markers CA 125, Squamous Cell Carcinoma Antigen, and Carcinoembryonic Antigen in Patients With Adenocarcinoma of the Uterine Cervix , 1989, Obstetrics and gynecology.

[14]  W. Mann,et al.  Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma , 1988, American journal of obstetrics and gynecology.

[15]  R. Bast,et al.  Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease. , 1988, American journal of obstetrics and gynecology.

[16]  G. Fleuren,et al.  CA 125: a useful marker in endometrial carcinoma. , 1986 .

[17]  H. Egami,et al.  Clinical Significance of Serum CA125 Values in Patients with Cancers of the Digestive System , 1986, The American journal of the medical sciences.

[18]  J A Blessing,et al.  Surgical Staging in Endometrial Cancer: Clinical—Pathologic Findings of a Prospective Study , 1984, Obstetrics and gynecology.

[19]  R. Bast,et al.  Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix. , 1984, American journal of obstetrics and gynecology.

[20]  R. Bast,et al.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. , 1983, The New England journal of medicine.

[21]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .